GMED vs. OPRA
GMED (Globus Medical, Inc.) and OPRA (Opera Limited) are both stocks. GMED operates in Medical Devices (Healthcare), while OPRA operates in Internet Content & Information (Communication Services). Over the past 5 years, GMED returned -0.63%/yr vs 19.43%/yr for OPRA. At a 0.22 correlation, their price movements are largely independent.
Performance
GMED vs. OPRA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GMED achieves a -10.54% return, which is significantly lower than OPRA's 42.17% return.
GMED
- 1D
- 1.92%
- 1M
- -2.99%
- 6M
- -17.32%
- YTD
- -10.54%
- 1Y
- 36.75%
- 3Y*
- 8.91%
- 5Y*
- -0.63%
- 10Y*
- 12.07%
OPRA
- 1D
- -0.52%
- 1M
- 10.19%
- 6M
- 45.48%
- YTD
- 42.17%
- 1Y
- 9.17%
- 3Y*
- -4.32%
- 5Y*
- 19.43%
- 10Y*
- —
GMED vs. OPRA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
GMED Globus Medical, Inc. | -10.54% | 5.56% | 55.21% | -28.25% | 2.87% | 10.70% | 10.77% | 36.04% | -18.19% |
OPRA Opera Limited | 42.17% | -22.08% | 52.02% | 140.60% | -10.91% | -22.67% | -1.30% | 66.37% | -61.23% |
Correlation
The correlation between GMED and OPRA is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since Jul 27, 2018 | 0.22 |
The correlation between GMED and OPRA shifts across timeframes, from 0.15 (1 year) to 0.28 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
GMED:
$10.53B
OPRA:
$1.72B
GMED:
$4.28
OPRA:
$1.26
GMED:
18.23
OPRA:
15.23
GMED:
0.19
OPRA:
0.06
GMED:
3.45
OPRA:
2.70
GMED:
2.28
OPRA:
1.77
GMED:
$3.10B
OPRA:
$647.66M
GMED:
$1.58B
OPRA:
$378.92M
GMED:
$803.34M
OPRA:
$154.47M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GMED vs. OPRA — Risk / Return Rank
GMED
OPRA
GMED vs. OPRA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Globus Medical, Inc. (GMED) and Opera Limited (OPRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GMED | OPRA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.67 | ||
| Sortino ratioReturn per unit of downside risk | +1.27 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 1.05 | +0.15 |
| Calmar ratioReturn relative to maximum drawdown | 1.60 | 0.05 | +1.55 |
| Martin ratioReturn relative to average drawdown | 3.87 | 0.09 | +3.77 |
Loading charts...
Drawdowns
GMED vs. OPRA - Drawdown Comparison
The maximum GMED drawdown since its inception was -47.91%, smaller than the maximum OPRA drawdown of -72.85%. Use the drawdown chart below to compare losses from any high point for GMED and OPRA.
Loading charts...
Drawdown Indicators
| GMED | OPRA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -47.91% | -72.85% | +24.94% |
Max Drawdown (1Y)Largest decline over 1 year | -22.10% | -41.28% | +19.18% |
Max Drawdown (3Y)Largest decline over 3 years | -44.40% | -61.68% | +17.28% |
Max Drawdown (5Y)Largest decline over 5 years | -47.91% | -61.97% | +14.06% |
Max Drawdown (10Y)Largest decline over 10 years | -47.91% | — | — |
Current DrawdownCurrent decline from peak | -19.32% | -19.94% | +0.62% |
Average DrawdownAverage peak-to-trough decline | -15.33% | -40.90% | +25.57% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.13% | 23.37% | -14.24% |
Volatility
GMED vs. OPRA - Volatility Comparison
Globus Medical, Inc. (GMED) has a higher volatility of 13.69% compared to Opera Limited (OPRA) at 10.70%. This indicates that GMED's price experiences larger fluctuations and is considered to be riskier than OPRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GMED | OPRA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.69% | 10.70% | +2.99% |
Volatility (6M)Calculated over the trailing 6-month period | 25.33% | 39.68% | -14.35% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.46% | 52.04% | -2.58% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 38.27% | 60.50% | -22.23% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.68% | 64.11% | -28.43% |
Dividends
GMED vs. OPRA - Dividend Comparison
GMED has not paid dividends to shareholders, while OPRA's dividend yield for the trailing twelve months is around 4.17%.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
GMED Globus Medical, Inc. | 0.00% | 0.00% | 0.00% | 0.00% |
OPRA Opera Limited | 4.17% | 5.65% | 4.22% | 8.92% |
Financials
GMED vs. OPRA - Financials Comparison
This section allows you to compare key financial metrics between Globus Medical, Inc. and Opera Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GMED vs. OPRA - Profitability Comparison
GMED - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported a gross profit of 0.00 and revenue of 759.85M. Therefore, the gross margin over that period was 0.0%.
OPRA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Opera Limited reported a gross profit of 111.02M and revenue of 175.77M. Therefore, the gross margin over that period was 63.2%.
GMED - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported an operating income of 150.39M and revenue of 759.85M, resulting in an operating margin of 19.8%.
OPRA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Opera Limited reported an operating income of 30.43M and revenue of 175.77M, resulting in an operating margin of 17.3%.
GMED - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported a net income of 124.30M and revenue of 759.85M, resulting in a net margin of 16.4%.
OPRA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Opera Limited reported a net income of 24.79M and revenue of 175.77M, resulting in a net margin of 14.1%.
Frequently Asked Questions
GMED and OPRA have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GMED has higher volatility (13.69%) compared to OPRA (10.70%). In terms of maximum drawdown, GMED dropped -47.91% vs OPRA's -72.85%.
GMED currently has the higher Sharpe Ratio (0.71 vs 0.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GMED and OPRA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer